Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

He XX, Tu SM, Lee MH, Yeung SC.

Ann Oncol. 2011 Dec;22(12):2640-5. doi: 10.1093/annonc/mdr020. Epub 2011 Mar 17.

2.

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC.

Ann Oncol. 2012 Jul;23(7):1771-80. doi: 10.1093/annonc/mdr534. Epub 2011 Nov 22.

3.

Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Haring A, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A.

Scand J Urol. 2017 Feb;51(1):5-12. doi: 10.1080/21681805.2016.1271353. Epub 2017 Jan 13.

PMID:
28084175
4.

Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.

Xiao Y, Zhang S, Hou G, Zhang X, Hao X, Zhang J.

Tumour Biol. 2014 Mar;35(3):2035-45. doi: 10.1007/s13277-013-1270-5. Epub 2013 Oct 5.

PMID:
24096546
5.

Tumor features and survival after radical prostatectomy among antidiabetic drug users.

Joentausta RM, Kujala PM, Visakorpi T, Tammela TL, Murtola TJ.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):367-373. doi: 10.1038/pcan.2016.32. Epub 2016 Aug 9.

PMID:
27502739
6.

Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.

Lee SH, Yoon SH, Lee HS, Chung MJ, Park JY, Park SW, Song SY, Chung JB, Bang S.

Dig Liver Dis. 2016 Apr;48(4):435-40. doi: 10.1016/j.dld.2015.12.006. Epub 2015 Dec 21.

PMID:
26775128
7.

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.

Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM.

Circulation. 2005 Feb 8;111(5):583-90.

8.

Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.

Paulus JK, Williams CD, Cossor FI, Kelley MJ, Martell RE.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1418-1425. Epub 2016 Aug 5.

9.

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM.

Cancer. 2012 Mar 1;118(5):1202-11. doi: 10.1002/cncr.26439. Epub 2011 Jul 28.

10.

Metformin and survival in diabetic patients with breast cancer.

El-Benhawy SA, El-Sheredy HG.

J Egypt Public Health Assoc. 2014 Dec;89(3):148-53. doi: 10.1097/01.EPX.0000456620.00173.c0.

PMID:
25534180
11.

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.

Häggström C, Van Hemelrijck M, Zethelius B, Robinson D, Grundmark B, Holmberg L, Gudbjörnsdottir S, Garmo H, Stattin P.

Int J Cancer. 2017 Feb 1;140(3):611-617. doi: 10.1002/ijc.30480. Epub 2016 Nov 3.

12.

The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.

Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, Wang M, Qazilbash MH, Baladandayuthapani V, Berry D, Orlowski RZ, Lee MH, Yeung SC.

Br J Cancer. 2014 Jul 29;111(3):628-36. doi: 10.1038/bjc.2014.307. Epub 2014 Jun 12.

13.

Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.

Rascati K, Richards K, Lopez D, Cheng LI, Wilson J.

Diabetes Obes Metab. 2013 Oct;15(10):901-5. doi: 10.1111/dom.12103. Epub 2013 Apr 18.

PMID:
23531154
14.

Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.

Medairos RA, Clark J, Holoubek S, Kubasiak JC, Pithadia R, Hamid F, Chmielewski GW, Warren WH, Basu S, Borgia JA, Liptay MJ, Seder CW.

J Thorac Cardiovasc Surg. 2016 Jul;152(1):55-61.e1. doi: 10.1016/j.jtcvs.2016.03.094. Epub 2016 Apr 14.

PMID:
27157918
15.

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.

Arrieta O, Varela-Santoyo E, Soto-Perez-de-Celis E, Sánchez-Reyes R, De la Torre-Vallejo M, Muñiz-Hernández S, Cardona AF.

BMC Cancer. 2016 Aug 12;16:633. doi: 10.1186/s12885-016-2658-6.

16.

Metformin use and risk of prostate cancer: results from the REDUCE study.

Feng T, Sun X, Howard LE, Vidal AC, Gaines AR, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ.

Cancer Prev Res (Phila). 2015 Nov;8(11):1055-60. doi: 10.1158/1940-6207.CAPR-15-0141. Epub 2015 Sep 9.

17.

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ.

Eur Urol. 2013 Apr;63(4):709-16. doi: 10.1016/j.eururo.2012.12.004. Epub 2012 Dec 14.

18.

Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.

Kim HJ, Lee S, Chun KH, Jeon JY, Han SJ, Kim DJ, Kim YS, Woo JT, Nam MS, Baik SH, Ahn KJ, Lee KW.

Medicine (Baltimore). 2018 Feb;97(8):e0036. doi: 10.1097/MD.0000000000010036.

19.

Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.

Gosmanova EO, Canada RB, Mangold TA, Rawls WN, Wall BM.

Am J Med Sci. 2008 Sep;336(3):241-7. doi: 10.1097/MAJ.0b013e31816250e6.

PMID:
18794619
20.

Metformin use and survival after colorectal cancer: A population-based cohort study.

Mc Menamin ÚC, Murray LJ, Hughes CM, Cardwell CR.

Int J Cancer. 2016 Jan 15;138(2):369-79. doi: 10.1002/ijc.29720. Epub 2015 Aug 31.

Supplemental Content

Support Center